Experiment 688652

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismUrtica dioica (URTICACEAE)
CitationLOWE,FC: FAGELMAN,E:. (1999). PHYTOTHERAPY IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA: AN UPDATE.. 53(4)
Amount utilized
Compound isolated
DiseasePROSTAGLUTT FORTE WAS ALSO COMPARED WITH FINASTERIDE (PROSCAR) IN A COMPARATIVE TRIAL THAT DID NOT HAVE A PLACEBO CONTROL ARM; 489 PATIENTS WERE RANDOMIZED AND FOLLOWED UP FOR 48 WEEKS. THE IPSS IMPROVED FROM 11.3 TO 6.5 FOR PROSTAGLUTT-TREATED PATIENTS AND FROM 12.6 TO 6.9 IN FINASTERIDE-TREATED PATIENTS. ALTHOUGH THE IMPROVEMENT WAS SLIGHTLY GREATER IN THE FINASTERIDE-TREATED PATIENTS (5.7 VS 4.8), THERE WAS NO STATISTICAL SIGNIFICANCE BETWEEN THE TREATMENT GROUPS. IN TERMS OF IMPROVEMENT IN PEAK URINARY FLOW, PROSTAGLUTT-TREATED PATIENTS IMPROVED BY 1.9 ML/S AND FINASTERIDE-TREATED PATIENTS BY 2.7 ML/S (P=0.189), ALSO NOT STATISTICALLY SIGNIFICANT BETWEEN GROUPS. THE SIGNIFICANCE OF THIS STUDY IS OBVIOUSLY QUESTIONABLE WITHOUT A PLACEBO CONTROL ARM.
Number5
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE
ExtractTYPE EXT NOT STATED
GenderMALE